How Much Did Nutrisense Raise?
Funding & Key Investors

Nutrisense has successfully secured a significant capital injection, bringing its total funding to $25.1M. This latest financing round, which accounts for $25M, underscores the company's robust market position within the digital health sector. By leveraging this recent strategic investment, Nutrisense is well-positioned to accelerate its mission of democratizing metabolic health data through advanced continuous glucose monitoring technology.

The company's growth trajectory, marked by a transition from early-stage debt financing to a substantial Series A round, reflects increasing investor confidence in the scalability of personalized nutrition platforms. This capital infusion serves as a critical milestone, enabling the firm to expand its operational footprint and enhance its proprietary data-driven health insights.

What is Nutrisense?

Nutrisense
Hospitals & Physicians ClinicsMedical Practice ManagementHealthcare Services

Nutrisense operates at the intersection of health-tech and preventative medicine, providing a comprehensive platform that integrates continuous glucose monitoring (CGM) with personalized nutritional guidance. By enabling users to track the real-time impact of diet, exercise, sleep, and lifestyle choices on blood glucose levels, the company offers a unique accountability framework supported by registered dietitians. This holistic approach to metabolic health positions Nutrisense as a leader in the burgeoning personalized wellness market, where data-driven insights are increasingly replacing generalized dietary advice. The platform's ability to synthesize complex biometric data into actionable lifestyle recommendations provides a significant competitive advantage in the enterprise-level health and wellness space.

How much funding has Nutrisense raised?

Nutrisense has raised a total of $25.1M across 2 funding rounds:

2021

Debt

$73K

2022

Series A

$25M

Debt (2021): $73K with participation from PPP

Series A (2022): $25M led by 1315 Capital

Key Investors in Nutrisense

1315 Capital

1315 Capital is a healthcare-focused investment firm specializing in commercial-stage companies across the medtech, pharma, and health services sectors. They provide strategic capital and operational expertise to drive growth and market leadership in the healthcare industry.

PPP

Public-Private Partnership

What's next for Nutrisense?

With the successful closure of its latest funding round, Nutrisense is poised to scale its infrastructure and deepen its market penetration. The strategic focus will likely shift toward enhancing the platform's algorithmic capabilities and expanding its professional support network to accommodate a growing user base. As the company matures, the integration of its metabolic tracking technology into broader corporate wellness programs and clinical partnerships remains a key growth vector. By maintaining its focus on evidence-based health outcomes and user-centric design, Nutrisense is well-equipped to navigate the complexities of the digital health landscape and solidify its status as a cornerstone of the modern metabolic health ecosystem.

See full Nutrisense company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Hospitals & Physicians Clinics industry

Hospitals & Physicians ClinicsMedical Practice ManagementHealthcare ServicesMental Health & Rehabilitation Facilities
Hospitals & Physicians ClinicsMedical Practice ManagementHealthcare ServicesMental Health & Rehabilitation Facilities
Hospitals & Physicians ClinicsMedical Practice ManagementHealthcare ServicesMental Health & Rehabilitation Facilities
Hospitals & Physicians ClinicsMedical Practice ManagementHealthcare ServicesMedical Laboratories & Imaging CentersMental Health & Rehabilitation Facilities

Frequently Asked Questions Regarding Nutrisense Financial Insights

What are the most recent funding rounds that Nutrisense has completed, and what were the funding rounds?
Nutrisense has recently completed 2 funding rounds: Series A on Jul 13, 2022, Debt on Feb 22, 2021.
What is the total amount of funding Nutrisense has raised to date?
Nutrisense has raised a total of $25.1M in funding to date.
How many funding rounds has Nutrisense completed?
Nutrisense has completed 2 funding rounds.
How much funding did Nutrisense raise in its most recent funding round?
Nutrisense raised $25M in its most recent funding round.
Who are the lead investors in Nutrisense's latest funding round?
The lead investor in Nutrisense's latest funding round was 1315 Capital. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Nutrisense's history?
The largest funding round in Nutrisense's history was $25M.
See more information about Nutrisense